Myeloma: Daratumumab Plus Lenalidomide Improves MRD Outcomes ...Middle East

News by : (Medscape) -
Adding daratumumab to lenalidomide in maintenance therapy for multiple myeloma significantly reduced rates of minimal residual disease. Medscape Medical News

Hence then, the article about myeloma daratumumab plus lenalidomide improves mrd outcomes was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Myeloma: Daratumumab Plus Lenalidomide Improves MRD Outcomes )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار